Australia Targets Patients And Doctors In Biosimilar Awareness Campaign
This article was originally published in Scrip
The Australian government is seeking feedback on a biosimilar awareness initiative for health professionals and consumers that will benefit from A$20m ($14.5m) in funding over the 2015-2018 period.
You may also be interested in...
Roche plans to appeal against a penalty imposed by the Romanian competition authorities for implementing strategies that were said to delay the entry of competing biosimilar and generic products.
The EU association representing parallel traders says cheaper parallel imports are vital in keeping medicines affordable for member states.
The latest drug safety actions by the European Medicines Agency affect products for dermatological use and vaginal atrophy.